155 related articles for article (PubMed ID: 3110540)
1. Ascorbate regulation of collagen biosynthesis in Ehlers-Danlos syndrome, type VI.
Dembure PP; Janko AR; Priest JH; Elsas LJ
Metabolism; 1987 Jul; 36(7):687-91. PubMed ID: 3110540
[TBL] [Abstract][Full Text] [Related]
2. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI.
Yeowell HN; Walker LC; Marshall MK; Murad S; Pinnell SR
Arch Biochem Biophys; 1995 Aug; 321(2):510-6. PubMed ID: 7646078
[TBL] [Abstract][Full Text] [Related]
3. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
[TBL] [Abstract][Full Text] [Related]
4. Inherited human collagen lysyl hydroxylase deficiency: ascorbic acid response.
Elsas LJ; Miller RL; Pinnell SR
J Pediatr; 1978 Mar; 92(3):378-84. PubMed ID: 416188
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of variants of the Ehlers-Danlos syndrome type VI.
Ihme A; Risteli L; Krieg T; Risteli J; Feldmann U; Kruse K; Müller PK
Eur J Clin Invest; 1983 Aug; 13(4):357-62. PubMed ID: 6413223
[TBL] [Abstract][Full Text] [Related]
6. Collagen synthesis by cultured skin fibroblasts from siblings with hydroxylysine-deficient collagen.
Quinn RS; Krane SM
Biochim Biophys Acta; 1979 Jul; 585(4):589-98. PubMed ID: 465542
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral gene transfer restores lysyl hydroxylase activity in type VI Ehlers-Danlos syndrome.
Rauma T; Kumpumäki S; Anderson R; Davidson BL; Ruotsalainen H; Myllylä R; Hautala T
J Invest Dermatol; 2001 Apr; 116(4):602-5. PubMed ID: 11286629
[TBL] [Abstract][Full Text] [Related]
8. Abnormal properties of collagen lysyl hydroxylase from skin fibroblasts of siblings with hydroxylysine-deficient collagen.
Quinn RS; Krane SM
J Clin Invest; 1976 Jan; 57(1):83-93. PubMed ID: 173744
[TBL] [Abstract][Full Text] [Related]
9. Genotyping and prenatal assessment of collagen lysyl hydroxylase deficiency in a family with Ehlers-Danlos syndrome type VI.
Dembure PP; Priest JH; Snoddy SC; Elsas LJ
Am J Hum Genet; 1984 Jul; 36(4):783-90. PubMed ID: 6089551
[TBL] [Abstract][Full Text] [Related]
10. Regulation of collagen synthesis by ascorbic acid.
Murad S; Grove D; Lindberg KA; Reynolds G; Sivarajah A; Pinnell SR
Proc Natl Acad Sci U S A; 1981 May; 78(5):2879-82. PubMed ID: 6265920
[TBL] [Abstract][Full Text] [Related]
11. A common duplication in the lysyl hydroxylase gene of patients with Ehlers Danlos syndrome type VI results in preferential stimulation of lysyl hydroxylase activity and mRNA by hydralazine.
Yeowell HN; Walker LC; Murad S; Pinnell SR
Arch Biochem Biophys; 1997 Nov; 347(1):126-31. PubMed ID: 9344473
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 gene.
Walker LC; Teebi AS; Marini JC; De Paepe A; Malfait F; Atsawasuwan P; Yamauchi M; Yeowell HN
Mol Genet Metab; 2004 Dec; 83(4):312-21. PubMed ID: 15589118
[TBL] [Abstract][Full Text] [Related]
13. Molecular defects in the Ehlers-Danlos syndrome.
Pinnell SR
J Invest Dermatol; 1982 Jul; 79 Suppl 1():90s-92s. PubMed ID: 7086195
[TBL] [Abstract][Full Text] [Related]
14. Regulation of collagen biosynthesis by ascorbic acid: a review.
Pinnell SR
Yale J Biol Med; 1985; 58(6):553-9. PubMed ID: 3008449
[TBL] [Abstract][Full Text] [Related]
15. Ehlers-Danlos syndrome type VI with normal lysyl hydroxylase activity cannot be explained by a defect in cellular uptake of ascorbic acid.
Royce PM; Moser U; Steinmann B
Matrix; 1989 Mar; 9(2):147-9. PubMed ID: 2498625
[TBL] [Abstract][Full Text] [Related]
16. Collagen biosynthesis and isomorphism in a case of Ehlers-Danlos syndrome type VI.
Chamson A; Berbis P; Fabre JF; Privat Y; Frey J
Arch Dermatol Res; 1987; 279(5):303-7. PubMed ID: 3115194
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characteristics of Ehlers-Danlos syndrome type VI in a family with one affected infant.
Krieg T; Feldmann U; Kessler W; Müller PK
Hum Genet; 1979 Jan; 46(1):41-9. PubMed ID: 429005
[TBL] [Abstract][Full Text] [Related]
18. Ehlers-Danlos syndrome type VI: clinical manifestations of collagen lysyl hydroxylase deficiency.
Wenstrup RJ; Murad S; Pinnell SR
J Pediatr; 1989 Sep; 115(3):405-9. PubMed ID: 2504907
[TBL] [Abstract][Full Text] [Related]
19. Differences between proline and lysine hydroxylations in their inhibition by zinc or by ascorbate deficiency during collagen synthesis in various cell types.
Anttinen H; Puistola U; Pihlajaniemi T; Kivirikko KI
Biochim Biophys Acta; 1981 May; 674(3):336-44. PubMed ID: 6263355
[TBL] [Abstract][Full Text] [Related]
20. Prolyl and lysyl hydroxylase activities of human skin fibroblasts: effect of donor age and ascorbate.
Murad S; Sivarajah A; Pinnell SR
J Invest Dermatol; 1980 Nov; 75(5):404-7. PubMed ID: 6253574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
